Medical devices, healthcare technology and the business of care
510(k) clearance · K261580

ZBPro Diagnostic (Version 2.0)

Zbeats, Inc. · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK261580

What did the FDA decide?

FDA's 510(k) record K261580 covers ZBPro Diagnostic (Version 2.0), submitted by Zbeats, Inc. of Stony Brook, New York, with Zaliance Medical Solutions, LLC listed as correspondent. The device falls under the classification name Electrocardiograph, Ambulatory, With Analysis Algorithm, regulation number 870.2800, product code MLO, in the Cardiovascular specialty and review panel. The application was received on 05/13/2026 and recorded as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan.

On 09/11/2026, FDA recorded a decision of Substantially Equivalent (SESE), which for a 510(k) means clearance to market, not premarket approval. The record does not describe the specific components, algorithm changes, or performance data behind Version 2.0, and no summary statement is present in the public information, so the basis for the equivalence determination remains unknown from this source.

The public record also does not identify a predicate device or summarize any clinical evidence, so the scope of what was cleared should be read from the FDA documents rather than inferred here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261580
Regulatory pathway
510(k) premarket notification
Applicant
Zbeats, Inc.
Product code
MLO
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Electrocardiograph, Ambulatory, With Analysis Algorithm.

Applicant
Zbeats, Inc.
Product code
MLO
FDA device class
2

FDA decision timeline

  1. K261580 received

    Application receipt date recorded by FDA.

  2. K261580 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zbeats, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Stony Brook, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records